Consumers have discovered the mood, stress, sleep and other health benefits of this natural root extract, leading market researchers to project a global market value of $2.5 billion by 2031 for ashwagandha supplements
It depends on baseline status and goals
Clinical Update 7/31/2019 Fresh vs
The study found that people taking GLP-1 medications had: 74% lower odds of alcohol use disorder 69% lower odds of opioid use disorder 68% lower odds of nicotine use disorder 75% lower odds of cocaine use disorder The study was published in Frontiers in Psychiatry
C., Trevisan, R., Parameswaran, S., Chvez-Iiguez, J
Thus, short-term CIT supplementation did not reduce blood pressure or arterial stiffness in this population (43)